The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis-Reference-Cited by-同舟云学术

The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis

Published:2019-05 Issue: Volume:127 Page:1-8
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Lozano-Ortega Greta,Walker David,Rogula Basia,Deighton Alison,Johnston Karissa^ORCID,Hawkins Neil,Dmochowski Roger

Publisher

Elsevier BV

Subject

Urology

Reference38 articles.

1. National community prevalence of overactive bladder in the United States stratified by sex and age;Coyne;Urology,2011

2. Overactive bladder significantly affects quality of life;Abrams;Am J Manage Care,2000

3. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment;Gormley;J Urol,2015

4. Retrospective study of utilization patterns of overactive bladder therapy in men in a commercially insured population: the early us mirabegron experience;Ng;Value Health,2015

5. A cost-effectiveness analysis of Onabotulinumtoxin A as first-line treatment for overactive bladder;Shepherd;Int Urogynecol J,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Utility Analysis of Mirabegron Compared to Solifenacin in the Treatment of Overactive Bladder (OAB) in Iran;Iranian Journal of Pharmaceutical Research;2023-11-08

2. Chemodenervation in Urology;Urologic Clinics of North America;2022-05

3. Treatment of idiopathic overactive bladder with botulinum toxin: real-life results and patients’ expectations;Porto Biomedical Journal;2022-03

4. Effects of β3 Agonists and Anticholinergic Drugs on Defecation in Patients With Overactive Bladder;In Vivo;2022

5. Pharmacological Management of Urinary Incontinence: Current and Emerging Treatment;Clinical Pharmacology: Advances and Applications;2021-11